Moderna
Moderna
Moderna (/məˈdɜːrnə/) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA (mRNA).
Etymology
The name "Moderna" is a blend of the words "modified" and "RNA", reflecting the company's focus on mRNA technology.
History
Moderna was founded in 2010 by Noubar Afeyan, Robert Langer, Derrick Rossi, and others. The company's initial funding came from venture capital firms Flagship Pioneering, Viking Global Investors, and Alexandria Venture Investments.
mRNA Technology
Moderna's primary innovation is its use of messenger RNA (mRNA) to stimulate the body's own cells to produce proteins that can prevent, treat, or cure disease. This technology was used to develop the Moderna COVID-19 Vaccine, which was authorized for emergency use in the United States in December 2020.
Related Terms
- mRNA: A type of RNA molecule that conveys genetic information from DNA to the ribosome, where they specify the amino acid sequence of the protein products of gene expression.
- Vaccine: A biological preparation that provides active acquired immunity to a particular infectious disease.
- COVID-19: An infectious disease caused by the SARS-CoV-2 virus, first identified in December 2019 in Wuhan, China.
- Pandemic: An epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of people.
External links
- Medical encyclopedia article on Moderna
- Wikipedia's article - Moderna
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski